Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,120.00
Bid: 4,120.00
Ask: 4,300.00
Change: -40.00 (-0.96%)
Spread: 180.00 (4.369%)
Open: 4,120.00
High: 4,120.00
Low: 4,120.00
Prev. Close: 4,160.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

28 Sep 2010 13:16

RNS Number : 4365T
North Atlantic Smlr Co Inv Tst PLC
28 September 2010
 



North Atlantic Smaller Companies Investment Trust plc

Half Yearly Financial Report

31 July 2010

 

 

The Directors of North Atlantic Smaller Companies Investment Trust plc report the unaudited results of the Company for the six months ended 31 July 2010.

 

 

Objective of the company and financial highlights 

 

The objective of the Company is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

31 July

31 January

2010

2010

%

(unaudited)

(audited)

Change

Net asset value per 5p Ordinary Share*:

Basic

1,521p

1,480p

2.8 

Diluted

1,335p

1,169p

14.2 

Mid-market price of the 5p Ordinary Shares

975.0p

814.0p

19.8 

Discount to diluted net asset value*

27.0%

30.4%

Standard & Poor's 500 Composite Index**

702.2

671.8

4.5 

Russell 2000 Index**

414.9

376.6

10.2 

FTSE All-Share Index

2,715.4

2,660.5

2.1 

US Dollar/Sterling exchange rate

1.5661

1.6024

(2.3)

* Including retained revenue for the period. ** Sterling adjusted.

 

 

chief executive's review

 

It is pleasing to report that the net asset value of the Company rose by 14.2% as compared with a rise in the Sterling Adjusted Standard & Poors Composite Index of 4.5%.

 

Income for the period amounted to £1,880,000 (31 January 2010: £443,000; 31 July 2009: loss of £105,000). Consistent with past policy, the Directors do not intend to pay a dividend.

 

During the six month period the Company purchased for cancellation 1,139,000 Ordinary Shares and 1,085,000 Convertible Loan Notes. These securities were purchased at a significant discount to the net asset value and therefore benefited the net asset value of the Trust.

 

quoted investments

 

The major achievements during the six month period were undoubtedly the takeovers of Castle Support Services and Inspired Gaming, both at premiums in excess of 40% above the end January valuation. In the case of Castle Support Services, the profit on original underlying cost exceeded £30 million.

 

unquoted investments

 

The principal change here was the redemption of the Avanti Communications Loan Notes at a 5% premium to par value, realising over £6.0 million. No new investments were made during the period. It is, however, encouraging to note that, with the exception of Performance Chemicals, all the businesses we own are performing in line or better than expectations and I am therefore confident that further value for shareholders will be generated from this part of the portfolio over the next few years.

 

outlook

 

Equity markets continue to be highly volatile and in my opinion it will be hard to make much progress in the short term as the inevitable impact of lower Government expenditure will be at best mediocre economic growth. Corporate profits have held up well as companies have cut costs but it is unlikely that equity markets will make any meaningful progress until there is a consumer sales led recovery, which seems unlikely in the current environment.

 

Following the sales referred to above, the Company now has approximately £49 million of cash or short dated Treasury Bills awaiting new investment opportunities. On this basis, I believe we are well placed for the future, even if overall equity markets continue to drift.

 

C H B Mills Chief Executive

28 September 2010

 

 

Top ten investments

as at 31 July 2010

 

Fair value

% of

Company

£'000

net assets

US Treasury Bills

US Treasury Stock

22,853

10.5

Bionostics Holdings Limited

UK Unquoted

21,112

9.7

Oryx International Growth Fund Limited*+

UK Listed

17,055

7.8

RPC Group PLC

UK Listed

10,640

4.9

BBA Aviation Group PLC

UK Listed

9,800

4.5

Nationwide Accident Repair Services PLC

UK Quoted on AIM

8,000

3.7

Orthoproducts Limited

UK Unquoted

7,787

3.6

Trident Private Equity Fund III LP

UK Unquoted

7,522

3.5

Gleeson (MJ) Group PLC

UK Listed

7,188

3.3

AssetCo Limited (Abu Dhabi)

UK Unquoted

7,020

3.2

118,977

54.7

 

* Incorporated in Guernsey

+ Oryx is accounted for in the Group accounts as an Associate under the equity method of accounting. The valuation shown above is the Group's share of Oryx's net assets. All other investments are valued at fair value.

 

 

interim management report

 

investment objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

material events

On 8 April 2010 the Board announced that, pursuant to the exercise of options granted under the Company's 1994 Executive Share Option Scheme, 100,000 ordinary shares of 5p each in the Company were issued and allotted. Following this allotment, the total issued share capital of the Company increased to 14,924,227 Ordinary shares. 

On 6 July 2010 the Company purchased 1,139,000 Ordinary shares of 5p each for cancellation representing approximately 7.63% of the issued share capital at a price of 930p per share. The issued share capital following cancellation was 13,785,227 Ordinary shares.

 

Upon admission of the new Ordinary shares as a result of the conversion of loan stock as set out below, the new issued share capital was 14,292,252 Ordinary shares with voting rights.

 

material transactions

On 2 June 2010 the Board announced an agreed takeover offer of Castle Support Services Plc. The transaction proved to be extremely successful and the impact on the net asset value at 31 May 2010 was an increase of approximately 5%.

 

risk profile

The principal risks and uncertainties for the remaining six months of the year continue to be as described in the Annual Report for the year ended 31 January 2010 on pages 68 to 78.The principal risks arising from the Group's financial instruments are market price risk and foreign currency risk. The Directors review and agree policies with the Joint Manager, North Atlantic Value LLP, for managing these risks. The policies have remained substantially unchanged in the six months since the year end.

The Group does not have any significant exposure to credit risk arising from any one individual party. Credit risk is spread across a number of companies, each having an immaterial effect on the Group's cash flows, should a default occur.

To support its investment in unquoted companies, the Group may periodically agree to guarantee all or part of the borrowings of investee companies. Provision is made for any costs that may be incurred when the Directors consider it likely that the guarantee will crystallise.

The Group's exposure to market price risk comprises mainly movements in the value of the Group's investments. It should be noted that the prices of options tend to be more volatile than the prices of the underlying securities.

The functional and presentational currency of the Group is Sterling, and therefore, the Group's principal exposure to foreign currency risk comprises investments priced in other currencies, principally US Dollars.

The Group invests in equities and other investments that are readily realisable.

 

related party transactions

These are listed in note 10 to the half yearly condensed financial statements.

 

CULS

The CULS were issued in units of 5p each. The units are redeemable at par on 31 May 2013, unless previously redeemed, purchased by the Company, or converted at the option of the holder.

During the period ended 31 July 2010, 507,025 (2009: 28,679) units of CULS were converted into Ordinary Shares of 5p each at the rate of one 5p Ordinary Share for every unit of 5p. On 4 June 2010, the Company purchased 1,085,000 units of CULS for cancellation at a price of 875p per unit (2009: Nil). As at 31 July 2010 there were 1,995,800 units of CULS outstanding.

The CULS units are convertible into Ordinary Shares of 5p each at a rate of one Ordinary Share for every 5p unit, one month after despatch of the audited accounts in each of the years 2010 to 2013 inclusive.

Interest is payable to holders of the CULS at a rate of 0.5p gross per 5p unit per annum on 31 January each year.

C H B Mills Chief Executive

28 September 2010

 

 

 

responsibility statement

The Directors confirm to the best of their knowledge that:

• The condensed set of financial statements contained within this half yearly financial report have been prepared in accordance with International Accounting Standard 34 'Interim Financial Reporting' as adopted by the European Union and gives a true and fair view of the assets, liabilities, financial position and profit of the Group; and

• The half yearly financial report includes a fair review of the information required by the FSA's Disclosure and Transparency Rule 4.2.7R being disclosure of important events that have occurred during the first six months of the financial year, their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the year; and

• The half yearly financial report includes a fair review of the information required by the FSA's Disclosure and Transparency Rule 4.2.8R being disclosure of related party transactions during the first six months of the financial year, how they have materially affected the financial position of the Group during the period and any changes therein.

The half yearly financial report was approved by the Board on 28 September 2010 and the above responsibility statement was signed on its behalf by:

The Hon. P D Moncreiffe Chairman

 

condensed consolidated statement of comprehensive income

 

Six months ended

Six months ended

31 July

31 July

2010

2009

(unaudited)

(unaudited)

Revenue

Capital

Total

Revenue

Capital

Total

£'000

£'000

£'000

£'000

£'000

£'000

Investment income

874 

874 

1,058 

1,058 

Net gains on investments at

fair value through profit or loss

20,568 

20,568 

14,070 

14,070 

Currency exchange gains

559 

559 

225 

225 

total income

874 

21,127 

22,001 

1,058 

14,295 

15,353 

Expenses

Investment management

 fee (note 2)*

(1,127)

(500)

(1,627)

(480)

(422)

(902)

Share based remuneration (note 7)

2,544

2,544

Other expenses

(320)

(320)

(548)

(548)

Share of net return of associate

1,350 

1,350 

2,985 

2,985 

profit before finance costs and taxation

1,971 

21,977 

23,948 

30 

16,858 

16,888 

Finance costs

(91)

-

(91)

(133)

(133)

profit/(loss) before taxation

1,880 

21,977 

23,857 

(103)

16,858 

16,755 

Taxation

(2)

-

(2)

profit/(loss) for the period

1,880 

21,977 

23,857 

(105)

16,858 

16,753 

other comprehensive income

total comprehensive income/(loss) for the period

1,880 

21,977 

23,857 

(105)

16,858 

16,753 

earnings per ordinary share (note 4)

Basic

161.49p

113.22p

Diluted

132.92p

89.87p

 

All of the profit/ (loss) for the period and the total comprehensive income/(loss) for the period is attributable to the owners of the Group.

The total column of the statement is the Statement of Comprehensive Income of the Group prepared in accordance with IFRS. The supplementary revenue and capital columns are presented for information purposes as recommended by the Statement of Recommended Practice issued by the Association of Investment Companies.

All items in the above Statement derive from continuing operations. No operations were acquired or discontinued in the period.

 

* Six months ended 31 January 2009 and year ended 31 January 2010 net of VAT refund.

 

 

condensed consolidated statement of comprehensive income (continued)

Year ended

31 January

2010

(audited)

Revenue

Capital

Total

£'000

£'000

£'000

Investment income

3,525

-

3,525

Net gains on investments at

fair value through profit or loss

-

38,531

38,531

Currency exchange gains

-

1,087

1,087

total income

3,525

39,618

43,143

Expenses

Investment management

fee (note 2)

(1,862)

(1,225)

(3,087)

Share based remuneration (note 7)

-

-

-

Other expenses

(973)

-

(973)

Share of net return of associate

-

4,477

4,477

profit before finance costs

and taxation

690

42,870

43,560

Finance costs

(242)

-

(242)

profit before taxation

448

42,870

43,318

Taxation

(5)

-

(5)

profit for the year

443

42,870

43,313

other comprehensive income

-

-

-

total comprehensive income

for the year

443

42,870

43,313

earnings per ordinary share (note 4)

Basic

292.44p

Diluted

233.42p

 

All of the profit for the year and the total comprehensive income for the year is attributable to the owners of the Group.

The total column of the statement is the Statement of Comprehensive Income of the Group prepared in accordance with IFRS. The supplementary revenue and capital columns are presented for information purposes as recommended by the Statement of Recommended Practice issued by the Association of Investment Companies.

All items in the above Statement derive from continuing operations. No operations were acquired or discontinued in the year.

 

 

condensed consolidated statement of changes in equity

 

Capital

Share

Share

Share

 

Redemption

CULS

options

premium

Capital

Revenue

capital

 

reserve

reserve

reserve

account

reserve

reserve

Total

£'000

 

£'000

£'000

£'000

£'000

£'000

£'000

£'000

six months ended 31 July 2010

(unaudited)

31 January 2010

741 

-

27

1,348 

629

218,665 

(1,949)

219,461 

Total comprehensive income for the period

-

-

-

-

21,977 

1,880 

23,857 

Issue of new ordinary shares

-

-

-

673

-

678 

Shares purchased for cancellation

(57)

 

57

-

-

-

(10,667)

-

(10,667)

Arising on conversion of CULS

26 

 

-

(4)

-

-

-

22 

Premium paid on repurchase of CULS for cancellation

-

(8)

-

-

(9,496)

-

(9,504)

Exercise of management options

-

-

-

(5,891)

-

-

(5,891)

Share option expense

-

-

(504)

-

-

(504)

31 July 2010

715 

57

15

(5,047)

1,302

220,479 

(69) 

217,452 

year ended 31 January 2010

(audited)

31 January 2009

740 

-

29

1,348

629

177,766

(2,392)

178,120 

Total comprehensive income for the year

-

-

-

-

42,870 

443 

43,313 

Premium paid on repurchase of CULS for cancellation

-

-

-

-

(1,971)

-

(1,971)

Arising on conversion of CULS

 

-

(2)

-

-

-

-

(1)

31 January 2010

741 

-

27

1,348

629

218,665

(1,949)

219,461 

six months ended 31 July 2009

(unaudited)

31 January 2009

740 

-

29

1,348

629

177,766

(2,392)

178,120

Total comprehensive income for the period

-

-

-

-

16,858

(105)

16,753

Arising on conversion of CULS

 

-

-

-

-

-

-

1

31 July 2009

741 

-

29

1,348

629

194,624

(2,497)

194,874

 

condensed consolidated balance sheet 

 

31 July

31 January

31 July

2010

2010

2009

(unaudited)

(audited)

(unaudited)

£'000

£'000

£'000

non current assets

Investments at fair value through profit or loss

164,951

179,670

153,294

Investments accounted for using the equity method

17,055

15,705

14,213

182,006

195,375

167,507

current assets

Investments held by Subsidiary Companies for trading

367

634

367

Trade and other receivables

15,266

2,018

3,582

Cash and cash equivalents

26,421

29,600

35,604

42,054

32,252

39,553

total assets

224,060

227,627

207,060

current liabilities

Bank loans and overdrafts

(5,624)

(5,864)

(7,358)

Investments held for trading - derivatives

-

(624)

(533)

Trade and other payables

(899)

(1,526)

(4,132)

(6,523)

(8,014)

(12,023)

total assets less current liabilities

217,537

219,613

195,037

non current liabilities

CULS

(85)

(152)

(163)

(85)

(152)

(163)

total liabilities

(6,608)

(8,166)

(12,186)

net assets

217,452

219,461

194,874

represented by:

Share capital

715

741

741

Capital redemption reserve

57

-

-

Equity component of CULS

15

27

29

Share options reserve

(5,047)

1,348

1,348

Share premium account

1,302

629

629

Capital reserve

220,479

218,665

194,624

Revenue reserve

(69)

(1,949)

(2,497)

equity attributable to equity holders

of the parent

217,452

219,461

194,874

net asset value per ordinary share (note 5):

Basic

1,521p

1,480p

1,315p

Diluted

1,335p

1,169p

1,029p

 

 

condensed consolidated cash flow statement

Six months

Six months

Year ended

ended 31 July

ended 31 July

31 January

2010

2009

2010

(unaudited)

(unaudited)

(audited)

Note

£'000

£'000

£'000

cash flows from operating activities

Investment income received

895

1,133

2,191

Bank deposit interest received

24

17

136

Other income

202

29

392

Purchase of investments by dealing Subsidiary

-

(341)

(839)

Sale of investments by dealing Subsidiary

-

-

8

Investment Manager's fees paid

(2,299)

(1,219)

(2,188)

Other cash payments

(344)

(53)

(472)

cash expended from operations

9

(1,522)

(434)

(772)

Bank interest paid

(87)

(188)

(306)

CULS interest paid

-

-

(18)

net cash outflow from operating activities

(1,609)

(622)

(1,096)

cash flows from investing activities

Purchases of investments

(37,885)

(71,870)

(120,767)

Sales of investments

58,811

82,218

128,383

net cash inflow from investing activities

20,926

10,348

7,616

cash flows from financing activities

Repayment of fixed term borrowings

-

(282)

(1,884)

Conversion of options

(3,851)

-

-

Issue of new shares

678

-

-

Shares purchased for cancellation

(10,667)

-

-

Repurchase of CULS for cancellation

(9,551)

-

(1,984)

net cash outflow from financing activities

(23,391)

(282)

(3,868)

(decrease)/increase in cash and cash equivalents for the period

(4,074)

9,444

2,652

cash and cash equivalents at the start of

 

the period

29,600

25,514

25,514

Revaluation of foreign currency balances

895

646

1,434

cash and cash equivalents at the end of the period

26,421

35,604

29,600

 

 

Notes

 

1. Basis of preparation

North Atlantic Smaller Companies Investment Trust plc ("NASCIT") is a Company incorporated and registered in England and Wales under the Companies Acts 1948 to 1967.

The condensed consolidated interim financial information for the six months ended 31 July 2010 have been prepared in accordance with IAS 34 "Interim Financial Reporting". They do not include all financial information required for full annual financial statements. They have been prepared using the accounting policies adopted in the audited financial statements for the year ended 31 January 2010. Those financial statements were prepared in accordance with International Financial Reporting Standards except as disclosed in note 2 of that report, and with the Statement of Recommended Practice ('SORP') for Investment Trust Companies and Venture Capital Trusts issued by the Association of Investment Companies in January 2009.

 

The condensed consolidated interim financial information consolidate the financial statements of the Company and its wholly owned Subsidiary, Consolidated Venture Finance Limited, for the six months ended 31 July 2010.

 

2. Investment management and performance fees

A Performance Fee is only payable if the investment portfolio outperforms the Sterling adjusted Standard & Poor's 500 Composite Index at the end of each financial year and is limited to a maximum payment of 0.5% of Shareholders' Funds.

In accordance with the Statement of Recommended Practice ("SORP") for investment trust companies, an amount is included in these financial statements for the Performance Fee that could be payable based on investment performance to 31 July 2010.

At that date, a Performance Fee of £500,000 including irrecoverable VAT has been accrued for in the accounts (31 July 2009: £422,000; 31 January 2010: £1,225,000) and is allocated 100% to capital. A £66,000 adjustment to irrecoverable VAT on the performance fee for the year to January 2010 has been made due to a change in the recoverable VAT rate of the Company.

 

3. Taxation

The Company has an effective tax rate of 0%. The estimated effective tax rate is 0% as investment gains are exempt from tax owing to the Company's status as an Investment Trust and there is expected to be an excess of management expenses over taxable income and thus there is no charge for corporation tax.

 

4. Earnings per ordinary share

Revenue

Capital

*Net

Per

*Net

Per

return

Ordinary

Share

return

Ordinary

Share

£'000

Shares

pence

£'000

Shares

pence

Six months ended 31 July 2010

(unaudited)

Basic return per Share

1,880 

14,772,954

12.72

21,977

14,772,954

148.77

CULS**

16 

3,186,922

-

3,186,922

Diluted return per Share

1,896 

17,959,876

10.55

21,977

17,959,876

122.37

Six months ended 31 July 2009

(unaudited)

Basic return per Share

(105)

14,796,974

(0.71)

16,858

14,796,974

113.93

CULS**

19 

3,865,078

-

3,865,078

Diluted return per Share

(86)

18,662,052

(0.46)

16,858

18,662,052

90.33

Year ended 31 January 2010

(audited)

Basic return per Share

443 

14,810,713

2.99

42,870

14,810,713

289.45

CULS**

19 

3,753,120

-

3,753,120

Diluted return per Share

462 

18,563,833

2.49

42,870

18,563,833

230.93

 

Basic return per Ordinary Share has been calculated using the weighted average number of Ordinary Shares in issue during the period.

* Net return on ordinary activities attributable to Ordinary Shareholders.

 

** CULS interest cost and excess of the total number of potential shares on CULS conversion over the number that could be issued at the average market price from the conversion proceeds, as calculated in accordance with IAS 33: Earnings per Share.

4. Earnings per ordinary share (continued)

Total

*Net

Per

return

Ordinary

Share

£'000

Shares

pence

Six months ended 31 July 2010

(unaudited)

Basic return per Share

23,857

14,772,954

161.49

CULS**

16

3,186,922

Diluted return per Share

23,873

17,959,876

132.92

Six months ended 31 July 2009

(unaudited)

Basic return per Share

16,753

14,796,974

113.22

CULS**

19

3,865,078

Diluted return per Share

16,772

18,662,052

89.87

Year ended 31 January 2010

(audited)

Basic return per Share

43,313

14,810,713

292.44

CULS**

19

3,753,120

Diluted return per Share

43,332

18,563,833

233.42

 

Basic return per Ordinary Share has been calculated using the weighted average number of Ordinary Shares in issue during the period.

* Net return on ordinary activities attributable to Ordinary Shareholders.

** CULS interest cost and excess of the total number of potential shares on CULS conversion over the number that could be issued at the average market price from the conversion proceeds, as calculated in accordance with IAS 33: Earnings per Share.

 

5. Net asset value per ordinary share

The basic net asset value per Ordinary Share is based on net assets of £217,452,000 (31 January 2010: £219,461,000; 31 July 2009: £194,874,000) and on 14,292,252 Ordinary Shares (31 January 2010: 14,824,227; 31 July 2009: 14,824,227) being the number of Ordinary Shares in issue at the period end.

The diluted net asset value per Ordinary Share is calculated on the assumption that the outstanding 2013 CULS are fully converted at par and that all 20,000 (31 January 2010: 1,017,500; 31 July 2009: 1,017,500) Share Options in-the-money were exercised at the prevailing exercise prices, giving a total of 16,308,052 issued Ordinary Shares (31 January 2010: 19,429,552; 31 July 2009: 19,679,552).

 

6. Debenture loan - convertible unsecured loan stock ('CULS') 2013

On 4 June 2010 1,085,000 CULS units were purchased for cancellation.

On 13 July 2010 507,025 CULS units were converted into 507,025 Ordinary shares of 5p each at a rate of one 5p Ordinary share for every unit of 5p.

At 31 July 2010 1,995,800 CULS units were remaining.

 

7. Share based remuneration

On 15 March 2010 C H B Mills (Mr Mills) exercised 100,000 share options granted in 2000 under the NASCIT 1994 Executive Share Option Scheme at an exercise price of 677.57p per share. With the approval of the Board, Mr Mills exercised these options at the strike price of 677.57p.

 

Accordingly, application was made and accepted, for 100,000 Ordinary Shares to be admitted to the Official List and be admitted to trading on the main market of the London Stock Exchange. Admission took place on 15 April 2010.

 

Further to a review of the NASCIT 2002 Executive Share Option Scheme, a majority of the option holders waived their rights to future participation. As part of the review of the incentive scheme, it was agreed that, subject to the proceeds being reinvested in NASCIT shares and those shares being held for a period of not less than two years, an ex gratia payment totalling £3.9 million be paid to Mr Mills and to those eligible employees of North Atlantic Value LLP.

 

The carrying value of these options was £6.4 million, resulting in a credit to the Statement of Comprehensive Income of £2.5 million.

 

8. Bank loans

The Company's multi-currency loan Revolving Credit Facility of up to £9 million was due to expire on 31 July 2010. During the period the Company negotiated an extension on this facility to 31 July 2011.

During the period the Company made no repayments. The Company currently has 6.8 million Euros drawn down which are due for repayment within the next six months.

 

9. Reconciliation of total return from ordinary activities before finance costs and taxation to cash expended from operations

Six months

Six months

Year ended

ended 31 July

ended 31 July

31 January

2010

2009

2010

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Profit/(loss) before finance costs and taxation*

23,948 

16,888 

43,560 

Gains on investments

(21,127)

(14,295)

(39,618)

Share based remuneration

(2,544)

Share of net return of associate

(1,350)

(2,985)

(4,477)

Dividends and interest reinvested

(588)

(297)

(837)

Decrease/(increase) in debtors and accrued income

59 

157 

(90)

Changes relating to investments of dealing Subsidiaries

710 

(280)

(568)

(Decrease)/increase in creditors and accruals

(630)

380 

1,263 

Tax on investment income

(2)

(5)

cash expended from operations

(1,522)

(434)

(772)

* including share of net return of associate

10. Related party transactions

There have been no changes to the related party arrangements or transactions as reported in the Statutory Annual Financial Report for the year ended 31 January 2010.

 

The Joint Manager, North Atlantic Value LLP, is regarded as a related party of the Company. The amounts payable to the Joint Manager and Growth Financial Services Limited ("GFS") in respect of investment management for the six months to 31 July 2010 are as follows:

Six months

Six months

Year ended

ended 31 July

ended 31 July

31 January

2010

2009

2010

(unaudited)

(unaudited)

(audited)

£'000

£'000

£'000

Annual fee

1,127

938

1,862

VAT reclaimed on Investment Management fees

-

(458)

-

Performance fee

472

422

1,102

Irrecoverable VAT thereon

28

-

123

1,627

902

3,087

In addition to the management fees disclosed above, North Atlantic Value LLP is also paid:

- an activity fee of £225 per transaction as reimbursement of custodian and related transaction costs incurred on the Company's behalf.

- an investment management related fee of £100,000 per annum.

 

Shareholders should also note the payments made under share based remuneration as disclosed in note 7 to these financial statements.

 

11. Financial information

The annual financial information contained in this half yearly report does not constitute full Statutory accounts as defined in Section 434 of the Companies Act 2006. The financial information for the periods ended 31 July 2010 and 31 July 2009 is not a financial year and has not been audited. The statutory accounts for the financial year ended 31 January 2010 have been delivered to the Registrar of Companies. Those accounts received a qualified audit opinion arising from the non consolidation of Bionostic Holdings and TPEIII. The Audit Report did not include any other reference to any matters to which the Auditors drew attention by way of emphasis without qualifying the Report and did not contain statements under Section 498(2) of the Companies Act 2006.

 

Shareholder information

 

Financial calendar

Preliminary results May Annual Report May Annual General Meeting June Half Yearly figures announced September Half Yearly Report posted September

Share price

The Company's mid-market share price and CULS price are quoted daily in the Financial Times appearing under "Investment Companies".

 

They also appear on:

Reuters: Convertible Loan Stock NASp.L Bloomberg: NAS. LN SEAQ Ordinary Shares: NAS Trustnet: www.trustnet.ltd.uk

 

Net asset value

The latest net asset value of the Company can be found on the North Atlantic Value LLP website:

www.navalue.co.uk

Share dealing

Investors wishing to purchase more Ordinary Shares or dispose of all or part of their holding may do so through a stockbroker. Many banks also offer this service.

The Company's registrars are Capita Registrars. In the event of any queries regarding your holding of shares, please contact the registrars on: 0871 664 0300 (calls cost 10p per minute plus network extras, lines are open 8.30am - 5.30pm Monday - Friday) or by email on ssd@capitaregistrars.com

Changes of name or address must be notified to the registrars in writing at:

Capita Registrars Northern House

Woodsome Park

Fenay Bridge

Huddersfield

West Yorkshire

HD8 0GA

 

The Half-Yearly Report will be posted to shareholders and loan stock holders in September 2010 and copies will be available on the North Atlantic Value LLP website www.navalue.co.uk or in hard copy format from the Company's registered office, Ground Floor, Ryder Court, 14 Ryder Street, London SW1Y 6QB.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR MMGZLZRFGGZM
Date   Source Headline
16th May 20242:46 pmRNSNet Asset Value(s)
14th May 202412:46 pmRNSTransaction in Own Shares
10th May 20247:00 amRNSFinal Results
17th Apr 202410:52 amRNSNet Asset Value(s)
12th Apr 20243:48 pmRNSHolding(s) in Company
8th Apr 20249:42 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202412:45 pmRNSTransaction in Own Shares - Replacement
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20243:55 pmRNSNet Asset Value(s)
15th Mar 202410:01 amRNSHolding(s) in Company
27th Feb 20247:00 amRNSDirector/PDMR Shareholding
19th Feb 202411:07 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSDividend Declaration
15th Feb 20247:00 amRNSNet Asset Value(s)
8th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20249:14 amRNSNew Investment: Crest Foods
5th Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSDirector/PDMR Shareholding
17th Jan 20243:32 pmRNSNet Asset Value(s)
27th Dec 20237:00 amRNSDirector Declaration
19th Dec 20237:00 amRNSNet Asset Value(s)
6th Dec 20237:41 amRNSInvestment Update: Ten Entertainment Group Plc
16th Nov 202312:44 pmRNSNet Asset Value(s)
30th Oct 20232:30 pmRNSTransaction in Own Shares
23rd Oct 20232:10 pmRNSTransaction in Own Shares
16th Oct 202312:19 pmRNSNet Asset Value(s)
12th Oct 20238:43 amRNSReplacement: Private Equity Investment Disposal
12th Oct 20237:00 amRNSPrivate Equity investment disposal
9th Oct 20233:02 pmRNSTransaction in Own Shares
15th Sep 20237:00 amRNSHalf-year Report
14th Sep 20231:43 pmRNSNet Asset Value(s)
31st Aug 20234:40 pmRNSCompany Secretary Change
29th Aug 20233:46 pmRNSTransaction in Own Shares - Replacement
29th Aug 20232:49 pmRNSTransaction in Own Shares
21st Aug 20233:07 pmRNSTransaction in Own Shares
16th Aug 20234:15 pmRNSTransaction in Own Shares
15th Aug 202310:03 amRNSNet Asset Value(s)
14th Aug 20232:09 pmRNSTransaction in Own Shares
8th Aug 20234:30 pmRNSTransaction in Own Shares
7th Aug 20234:28 pmRNSTransaction in Own Shares
25th Jul 202312:52 pmRNSNanoco Group Plc
18th Jul 20233:23 pmRNSNet Asset Value(s)
17th Jul 202312:41 pmRNSPortfolio Update
10th Jul 20239:39 amRNSTransaction in Own Shares
3rd Jul 202310:14 amRNSTransaction in Own Shares
30th Jun 202312:17 pmRNSDirector/PDMR Shareholding
26th Jun 202310:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.